FDA Needs to Share Trade Information, Shift Import Safety Burden to Industry, Official Says

Drug Industry Daily
ATHENS, Ga. — The FDA needs dramatic new powers from Congress, including the ability to share trade secrets and proprietary information with other regulators, to better police the drug industry’s supply chain, a top FDA official says.

To View This Article:


Subscribe To Drug Industry Daily